CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities
- 1 February 2016
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 41, 36-42
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- An overall characterization of pediatric acute lymphoblastic leukemia with CRLF2 overexpressionGenes, Chromosomes and Cancer, 2014
- Differences in signaling through the B-cell leukemia oncoprotein CRLF2 in response to TSLP and through mutant JAK2Blood, 2012
- IGH@ Translocations, CRLF2 Deregulation, and Microdeletions in Adolescents and Adults With Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2012
- Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemiasJournal of Experimental Medicine, 2011
- Modern Therapy of Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2011
- Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocolBlood, 2010
- Adult acute lymphoblastic leukemiaCancer, 2010
- Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemiaProceedings of the National Academy of Sciences, 2009
- Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemiaBlood, 2009
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007